Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molteno tube implants: long-term results.

W J Ward, R L Cooper

    Australian and New Zealand Journal of Ophthalmology
    |May 1, 1987
    PubMed
    Summary

    The Molteno implant effectively treats end-stage secondary glaucoma. Long-term follow-up (2-6 years) demonstrates its efficacy and provides insights into patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First Event-by-Event Identification of Cherenkov Radiation from Sub-Mev Particles in Liquid Argon.

    Physical review letters·2025
    Same author

    First Leptophobic Dark Matter Search from the Coherent-CAPTAIN-Mills Liquid Argon Detector.

    Physical review letters·2022
    Same author

    First Measurement of Coherent Elastic Neutrino-Nucleus Scattering on Argon.

    Physical review letters·2021
    Same author

    First Measurement of the Total Neutron Cross Section on Argon between 100 and 800 MeV.

    Physical review letters·2019
    Same author

    Significant Excess of Electronlike Events in the MiniBooNE Short-Baseline Neutrino Experiment.

    Physical review letters·2018
    Same author

    First Measurement of Monoenergetic Muon Neutrino Charged Current Interactions.

    Physical review letters·2018

    Area of Science:

    • Ophthalmology
    • Glaucoma Research
    • Surgical Interventions

    Background:

    • End-stage secondary glaucoma presents significant treatment challenges.
    • The Molteno implant is an established surgical option.
    • Limited long-term data exists for Molteno implant outcomes.

    Purpose of the Study:

    • To evaluate the long-term efficacy and safety of the Molteno implant.
    • To analyze patient outcomes following Molteno implant surgery for glaucoma.
    • To report on the indications and results of Molteno implant procedures.

    Main Methods:

    • Retrospective analysis of patients treated with Molteno implants.
    • Follow-up period ranging from two to six years.
    • Documentation of surgical indications and intraocular pressure control.

    Main Results:

    • The Molteno implant demonstrated sustained intraocular pressure reduction.
    • Analysis of complications and visual field progression.
    • Presentation of specific patient cohort results over 2-6 years.

    Conclusions:

    • The Molteno implant remains a viable option for refractory glaucoma.
    • Long-term data supports the use of Molteno implants in specific glaucoma cases.
    • Further research into implant variations and long-term management is warranted.

    Related Experiment Videos